Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 8/2019

01-11-2019 | Petechiae | IM - CASE RECORD

A 29-year-old woman with persistent thrombocytopenia

Authors: Irene Di Pasquale, Antonella Bertomoro, Fabrizio Vianello, Piero Marson, Francesca Boscaro, Fabrizio Fabris

Published in: Internal and Emergency Medicine | Issue 8/2019

Login to get access

Excerpt

Dr. Di Pasquale, Dr. Boscaro: In November 2013, a 29-year-old Moldovan woman was referred to our center with a platelet count of 4 × 109/L and bleeding symptoms such as epistaxis and petechiae. She had been diagnosed with immune thrombocytopenia (ITP) in 2002. Ever since her childhood, her thrombocytopenia had been associated with hemolytic anemia (Evans syndrome) requiring blood transfusions, and complicated by HCV-related hepatitis (anti-HCV antibodies, HCV-RNA 1257491 IU/ml, genotype 1b). Previous therapy for ITP, based on prednisone, intravenous immunoglobulin (IVIg) and azathioprine had been ineffective. In 2006, she underwent splenectomy, and achieved a stable complete remission (CR), maintained with a low daily dose of prednisone (2.5 mg). …
Literature
1.
Cines DB, Bussel JB, Liebman HA, Luning Prak ET (2009) The ITP syndrome: pathogenic and clinical diversity. Blood 113(26):6511–6521CrossRef
2.
Rodeghiero F, Stasi R, Gernsheimer T et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):2386–2393CrossRef
3.
McMillan R, Durette C (2004) Long-term outcomes in adults with chronic ITP after splenectomy failure. Blood 104(4):956–960CrossRef
4.
Broudy VC, Lin NL (2004) AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Cytokine 25:52–60CrossRef
5.
Kuter DJ, Bussel JB, Lyons RM et al (2008) Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 371:395–403CrossRef
6.
Bussel JB, Cheng G, Saleh MN et al (2007) Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 357:2237–2247CrossRef
7.
Cooper N (2017) State of the art—how I manage immune thrombocytopenia. Br J Haematol 177:39–54CrossRef
8.
Boruchov DM, Gururangan S, Driscoll MC, Bussel JB (2007) Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP). Blood 110:3526–3531CrossRef
9.
Mahévas M, Gerfaud-Valentin M, Moulis G, Terriou L, Audia S, Guenin S, Le Guenno G, Salles G, Lambotte O, Limal N, Viallard JF, Cheze S, Tomowiak C, Royer B, Neel A, Debouverie O, Hot A, Durieu I, Perlat A, Cliquennois M, Deteix C, Michel M, Godeau B (2016) Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia. Blood 128(12):1625–1630CrossRef
10.
Tauchi T, Suzuki A, Fujimura T, Iwabuchi H, Ohyashiki JH, Ohyashiki K et al (1989) Refractory idiopathic thrombocytopenic purpura which responded to protein A column. Rinsho Ketsueki 30(8):1289–1293PubMed
11.
Fabris F, Luzzatto G, Ramon R, Randi ML, De Silvestro G, Girolami A (2000) Treatment of refractory ITP with extracorporeal immunoadsorption over a protein-A sepharose column: a report of two cases. Haematologica 85(8):888–890
12.
Kurtoğlu E, Karakuş V, Deveci B (2013) Refractory idiopathic thrombocytopenic purpura treated with immunoadsorption using tryptophan column. Transfus Apheres Sci 48:311–312CrossRef
13.
Kotb R, Pinganaud C, Trichet C et al (2005) Efficacy of mycophenolate mofetil in adult refractory autoimmune cytopenias: a single-center preliminary study. Eur J Haematol 75(1):60–64CrossRef
14.
Taylor A, Neave L, Solanki S, Westwood JP, Terrinonive I, McGuckin S, Kothari J, Cooper N, Stasi R, Scully M (2015) Mycophenolate mofetil therapy for severe immune thrombocytopenia. Br J Haematol 171:625–630CrossRef
Metadata
Title
A 29-year-old woman with persistent thrombocytopenia
Authors
Irene Di Pasquale
Antonella Bertomoro
Fabrizio Vianello
Piero Marson
Francesca Boscaro
Fabrizio Fabris
Publication date
01-11-2019
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 8/2019
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02030-6

Other articles of this Issue 8/2019

Internal and Emergency Medicine 8/2019 Go to the issue

IM - COMMENTARY

Lormetazepam in oral solution: a formulation at risk of high-dose use

IM - REVIEW

The lung microbiome: clinical and therapeutic implications

CE - Research Letter to the Editor

Randomized trial of two after-dialysis gabapentin regimens for severe uremic pruritus in hemodialysis patients

IM - ORIGINAL

Identifying patients with refusal of percutaneous coronary intervention for acute myocardial infarction: a classification and regression tree analysis

IM - ORIGINAL

Focus on echocardiographic right ventricular strain analysis in cystic fibrosis adults without cardiovascular risk factors: a case–control study

IM - ORIGINAL

High-dose lormetazepam dependence: strange case of Dr. Jekyll and Mr. Hyde
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits